Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
NIHR Journals Library
2011-05-01
|
| Series: | Health Technology Assessment |
| Online Access: | https://doi.org/10.3310/hta15suppl1/07 |